{"id":"dmso-cocktail","_chembl":{"chemblId":"CHEMBL3188576","moleculeType":"Small molecule","molecularWeight":"1461.43"},"_dailymed":null,"_scrapedAt":"2026-03-28T04:36:01.594Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123410,"model":"claude-sonnet-4-5-20250929"},"description":"DMSO cocktail is an investigational combination therapy being studied by Assaf-Harofeh Medical Center in Phase 1 clinical trials. DMSO (dimethyl sulfoxide) is a solvent with potential anti-inflammatory and analgesic properties. The specific formulation and therapeutic target of this cocktail remain undisclosed.","indications":{"approved":[{"status":"investigational","condition":null,"patientPopulation":null}]},"trialDetails":[{"nctId":"NCT07020715","phase":"PHASE2","title":"A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2026-03-01","conditions":"Multiple Sclerosis","enrollment":14},{"nctId":"NCT01074567","phase":"NA","title":"DMSO Efficacy in IC/PBS Patients During and After Treatment","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2009-12","conditions":"Cystitis, Interstitial","enrollment":50},{"nctId":"NCT00317070","phase":"PHASE2","title":"Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC)","status":"TERMINATED","sponsor":"Nova Scotia Health Authority","startDate":"2006-04","conditions":"Interstitial Cystitis, Bladder Diseases","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":63,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Dimethyl sulfoxide"],"phase":"phase_1","status":"active","brandName":"DMSO cocktail","genericName":"DMSO cocktail","companyName":"Assaf-Harofeh Medical Center","companyId":"assaf-harofeh-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DMSO cocktail is a treatment used to study conditions such as interstitial cystitis and multiple sclerosis in clinical trials. It is a small molecule that acts as an inhibitor of the bacterial 70S ribosome, according to its classification in ChEMBL.","enrichmentLevel":2,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}